










































Induction of eosinophil apoptosis by hydrogen peroxide
promotes the resolution of allergic inflammation
Citation for published version:
Reis, AC, Alessandri, AL, Athayde, RM, Perez, DA, Vago, JP, Ávila, TV, Ferreira, TPT, de Arantes, ACS,
Coutinho, DDS, Rachid, MA, Sousa, LP, Martins, MA, Menezes, GB, Rossi, AG, Teixeira, MM & Pinho, V
2015, 'Induction of eosinophil apoptosis by hydrogen peroxide promotes the resolution of allergic
inflammation' Cell Death and Disease, vol. 6, pp. e1632. DOI: 10.1038/cddis.2014.580
Digital Object Identifier (DOI):
10.1038/cddis.2014.580
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Cell Death and Disease
Publisher Rights Statement:
Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed
under a Creative Commons Attribution 4.0 International Licence. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless indicated otherwise in the credit line; if the
material is not included under the Creative Commons licence, users will need to obtain permission from the
licence holder to reproduce the material. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
OPEN
Induction of eosinophil apoptosis by hydrogen
peroxide promotes the resolution of allergic
inflammation
AC Reis1,2,8, AL Alessandri3,8, RM Athayde1,2, DA Perez1,2, JP Vago4, TV Ávila5, TP T Ferreira6, ACS de Arantes6, D de Sá Coutinho6,
MA Rachid7, LP Sousa4, MA Martins6, GB Menezes1, AG Rossi3, MM Teixeira2 and V Pinho*,1,2
Eosinophils are effector cells that have an important role in the pathogenesis of allergic disease. Defective removal of these cells
likely leads to chronic inflammatory diseases such as asthma. Thus, there is great interest in understanding the mechanisms
responsible for the elimination of eosinophils from inflammatory sites. Previous studies have demonstrated a role for certain
mediators and molecular pathways responsible for the survival and death of leukocytes at sites of inflammation. Reactive oxygen
species have been described as proinflammatory mediators but their role in the resolution phase of inflammation is poorly
understood. The aim of this study was to investigate the effect of reactive oxygen species in the resolution of allergic inflammatory
responses. An eosinophilic cell line (Eol-1) was treated with hydrogen peroxide and apoptosis was measured. Allergic
inflammation was induced in ovalbumin sensitized and challenged mouse models and reactive oxygen species were administered
at the peak of inflammatory cell infiltrate. Inflammatory cell numbers, cytokine and chemokine levels, mucus production,
inflammatory cell apoptosis and peribronchiolar matrix deposition was quantified in the lungs. Resistance and elastance were
measured at baseline and after aerosolized methacholine. Hydrogen peroxide accelerates resolution of airway inflammation by
induction of caspase-dependent apoptosis of eosinophils and decrease remodeling, mucus deposition, inflammatory cytokine
production and airway hyperreactivity. Moreover, the inhibition of reactive oxygen species production by apocynin or in
gp91phox− /− mice prolonged the inflammatory response. Hydrogen peroxide induces Eol-1 apoptosis in vitro and enhances the
resolution of inflammation and improves lung function in vivo by inducing caspase-dependent apoptosis of eosinophils.
Cell Death and Disease (2015) 6, e1632; doi:10.1038/cddis.2014.580; published online 12 February 2015
Eosinophils express numerous receptors and secrete a wide
variety of inflammatory mediators that influence many innate
and adaptive immune responses. These multifunctional cells
are important in the defense against helminth infection and are
involved in the pathogenesis of many eosinophilic dominant
allergic diseases.1 High levels of eosinophil granule proteins
(such as major basic protein (MBP)) have been found in
bronchoalveolar lavage fluid from patients with asthma and
evidence indicates that high-concentration granule products
have contributed to the development of airway hyperreactivity
(AHR), a cardinal feature of asthma.2 Asthma is an inflamma-
tory disease of the airways with participation of many cell
types including leukocytes especially eosinophils and
lymphocytes.3,4 Activation of these cells (mainly lymphocytes)
leads to the release of proinflammatory mediators and
cytokines such as leukotriene B4, interleukin-4 (IL-4),
interleukin-5 (IL-5), interleukin-9 (IL-9), interleukin-13 (IL-13)
and colony-stimulating factor granulocyte-macrophage
(GM-CSF).3,5–7 Investigations using preclinical animal models
of asthma and clinical studies in patients with asthma have
demonstrated that the presence of eosinophils in the lungs are
associated with epithelial damage, goblet cell hyperplasia,
smooth muscle hypertrophy and airway hyperresponsiveness
resulting in airflow limitation which can be fatal.3,8–10 Recently,
anti-IL-5 treatment has been shown to ameliorate lung
function in patients with eosinophilic asthma.11
Apoptosis of leukocytes is regarded as an important
process for the successful resolution of inflammatory
responses. Reduced eosinophil apoptosis in bronchoalveolar
lavage (BAL) fluid has been shown to correlate positively
with severity of asthma.3,12–14 Indeed, defective leukocyte
apoptosis and subsequent removal of apoptotic cells by
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phagocytes is thought to be important for the initiation and
propagation of chronic inflammatory diseases such as
asthma.15 Therefore, a balance in the tissue microenviron-
ment between pro- and antiapoptotic signals is likely to greatly
influence the load of eosinophils in the asthmatic lung.16 Thus,
there is a great interest in understanding the mechanisms
responsible for the elimination of eosinophils and other
leukocytes and inactivation of proinflammatory mediators in
inflammatory sites.17
Several molecular pathways have been shown to modulate
the survival and death of leukocytes at sites of inflammation,
including reactive oxygen species (ROS).18 ROS are a family
of molecules containing oxygen and includes hydrogen
peroxide (H2O2), superoxide O2
−, hydroxyl radical (OH) and
nitric oxide (NO).19 In inflammatory conditions, ROS are
increased as they help in neutralizing invading organisms
during infection either directly or indirectly by formation of
extracellular traps (ETs).20 ROS have traditionally been
regarded as quintessentially proinflammatory. However, evi-
dence for ROS-mediated anti-inflammatory actions has been
described.21 The importance for ROS production in the
context of infection can be exemplified in patients with chronic
granulomatous disease (CGD) where defective production in
ROS results in multiple infections and often early death.22,23
Furthermore, studies in mouse models have shown that
NADPH oxidase is key for regulating lung inflammation and
injury as well as NF-κB activation and downstream cytokine
production in response to LPS.24 More recently, our group has
demonstrated that NADPH oxidase-derived H2O2 is directly
linked to induction of apoptosis of neutrophils and resolution of
inflammation in a model of antigen-induced arthritis.18
However, the role of ROS in the context of the resolution of
allergic inflammation is still unknown.
Here, we evaluated whether H2O2 drives apoptosis of
eosinophils and thereby influences the resolution of estab-
lished eosinophilic inflammation and reduction of airflow
obstruction. Our study provides evidence that H2O2 is
released during allergic inflammation in a gp91phox− /− -depen-
dent manner and induces a caspase-dependent proapoptotic
effect in eosinophils, thus having a crucial role in the resolution
of allergic inflammation.
Results
Kinetics of inflammation response after asthma induc-
tion in mice. We used a well-established murine model of
asthma previously described by Stock et al.25 In this
model, the inflammatory response was characterized by
accumulation of leukocytes detectable at 12 h and that
reached maximal at 24–48 h after challenge with OVA
(Supplementary Figure 1A). There was predominant accu-
mulation of neutrophils at 12 h after antigenic challenge
(Supplementary Figure 1B). Twenty-four hours after chal-
lenge, the number of neutrophils dropped and there was
increased accumulation of eosinophils. The natural resolution
of eosinophilic inflammation was initiated at 48 h and virtually
completed at 72 h after antigen challenge (Supplementary
Figure 1C). Likewise, similar results were obtained in an
allergic pleurisy model in which there is also acute
self-resolving eosinophilic inflammation (Supplementary
Figure 2A). Importantly, the increased number of mono-
nuclear cells at 12 h and 48 h after antigen challenge
coincided with the decrease of neutrophils and eosinophils,
respectively (Supplementary Figure 1D).
Treatment with H2O2 or SOD decreases eosinophil
accumulation in asthma models. Next experiments were
designed to investigate the ability of H2O2 to resolve
eosinophilic inflammation in vivo. We treated mice with
SOD or H2O2 24 h after OVA challenge, a time point at
which the number of neutrophils is close to basal levels and
eosinophil numbers are maximal. Treatment with SOD, which
increases production of endogenous H2O2, or exogenous
H2O2 treatment decreased the number of eosinophils in the
BAL (Figure 1a) and reduced the levels of eosinophilic
peroxidase (EPO) in the lung (Figure 1b). Treatment with
catalase, which degrades H2O2, prevented the proresolving
effects of SOD (Figures 1a and b). The lung parenchyma of
challenged mice exhibited intense infiltration of inflammatory
cells and loss of pulmonary architecture 48 h after antigen
challenge when compared with the control group (PBS)
(Figures 1c and d). Mice that received H2O2 at 24 h showed
reduced parenchymal inflammation (Figure 1e). Likewise,
treatment with SOD was associated with less parenchymal
inflammation and administration of catalase prevented the
anti-inflammatory actions of SOD (data not shown). Likewise,
similar results were obtained in an allergic pleurisy model
(Supplementary Figures 2B and C).
gp91phox deficiency extends the duration of allergic
inflammation. Because treatment with H2O2 resolved eosi-
nophilic inflammation, a series of experiments were then
performed in gp91phox− /− mice, which lack the ability to
assemble the NADPH oxidase and have decreased capacity
to generate ROS.18 ROS production in gp91phox−/− mice was
significantly lower when compared to wild-type mice
(Figure 2a). In these mice, natural resolution of eosinophilic
inflammation, which usually is complete within 72 h in WT
mice, was not observed even at 96 h after antigen challenge
(Figure 2b). Likewise, intranasal treatment with apocynin (an
inhibitor of NADPH oxidase) at a dose of 10mg/kg prevented
natural resolution of eosinophilic inflammation at 72 and 96 h
after challenge (Figure 2b).
The histopathological analysis of lung sections showed that
within 72 h the inflammation was present only in focal
segments in wild-type mice (WT) and lung tissue was mostly
preserved (Figure 2d). In contrast, there was much infiltration
of inflammatory cells and derangement of tissue architecture
at 72 h in gp91phox−/− mice exposed to antigen when
compared with the control group (PBS, Figures 2d and e).
H2O2 treatment induced caspase-dependent apoptosis of
eosinophils. Considering that the generation of endogen-
ous H2O2 (via treatment with SOD) and administration of
H2O2 reduced the number of eosinophils, we investigated
whether death of eosinophils via apoptosis could underlie the
resolution of eosinophilic inflammation. Indeed, there was
significant increase in the number of apoptotic eosinophils as
observed morphologically in mice treated with either SOD
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or H2O2 (Figures 3a and d–g and Supplementary Figure 2D)
and demonstrated by flow cytometric analysis (Figure 3b). In
mice treated with H2O2, there was an increase in expression
of annexin V-FITC+ in CCR3+ cells at 2 h after treatment
(Figure 3b). These data were confirmed by increased staining
for cleaved caspase-3 in eosinophils, but not in mononuclear
cells, in BAL from ova-challenged mice treated with H2O2
(Supplementary Figure 3). In contrast, T cells were not
affected by H2O2 (% of cells CD3+/AnnX-V+: PBS:
0.69±0.24; OVA: 0.74± 0.18, OVA+H2O2: 1.04±0.22
P40.05, n=6), suggesting that H2O2 treatment affected
eosinophils more specifically. Treatment of animals with
zVAD-fmk, a pan-caspase inhibitor, reversed the proresolu-
tion actions of H2O2, demonstrating the caspase dependency
of the resolution of eosinophilic inflammation (Figure 3c).
H2O2 induces concentration-dependent apoptosis of an
eosinophilic cell line in vitro. Next, we evaluated whether
H2O2 could induce directly the apoptosis of a human
eosinophil cell line, Eol-1. This cell line has been extensively
used as a model of eosinophil function, including chemotaxis,
mediator release and apoptosis induction.26,27 Eol-1 cells
were incubated for a 4-h period with increasing concentra-
tions of 0.3, 1.0 and 3.0mM H2O2. Annexin-V-positive
cells were considered apoptotic cells and annexin-V/PI
dual-positive cells were considered late apoptotic/secondarily
necrotic cells. H2O2 markedly increased apoptosis of Eol-1
cells in a concentration-dependent manner (Figure 4a). In
order to confirm that Eol-1 cells undergo apoptosis following
incubation with H2O2, Eol-1 was coincubated with H2O2 and
Q-VD-OPh, a highly effective pan-caspase inhibitor. Coin-
cubation of Eol-1 with Q-VD-OPh abrogated the ability of
H2O2 to induce apoptosis (Figure 4b). To demonstrate further
the role of caspase-3 in Eol-1 apoptosis induced by H2O2, we
performed western blot analysis to investigate expression of
cleaved caspase-3 on lysates from Eol-1 cells 4 h after
stimulation with different concentrations of H2O2. H2O2 caused
caspase-3 cleavage when compared with cells treated with
media alone (Figure 4c). Apoptosis was also assessed
morphologically using light microscopy after cytocentrifugation
and staining with Diff-Quick. We observed that apoptotic Eol-1
cells exhibited nuclear condensation and cellular shrinkage,
confirming flow cytometric data (data not shown).
H2O2 reduces airway hyperreactivity to methacholine.
Airway hyperreactivity (AHR) has been studied in a well-
established murine model of asthma.28 In this model, the
time course of the eosinophilic infiltrate was similar to that
Figure 1 H2O2 promotes resolution of inflammation in a mouse model of asthma. Number of eosinophils after administration of SOD (0.3 mg/kg), SOD+catalase (1.2 mg/kg),
H2O2 (0.5 M) or vehicle (30 μl PBS) (a). Eosinophil peroxidase (b). Photomicrographs of lung sections - PBS (c), asthma (d) H2O2 (e) H&E. 100 × . Scale 50 μm. Data represent
mean±S.E.M. (n= 5). *Po0.05 versus control mice. #Po0.05 versus OVA mice
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observed in our previous experiments (see Supplementary
Figure 4 and compare with Supplementary Figure 1). Akin to
experiments described previously, delayed treatment with
H2O2 resolved the eosinophilic infiltrate in the BAL at 48 h
after antigen challenge (Figures 5a and d) when compared
with the control group (PBS, Figures 5a and b). In these mice,
AHR was assessed by measuring airway resistance (RI)
and lung elastance parameters in mechanically ventilated
animals. As shown in Figure 6, antigen challenge with OVA
exacerbated airway resistance and elastance of the lungs in
response to inhaled methacholine (3–81mg/ml), as com-
pared with the control group challenged with PBS. Treatment
with H2O2 reduced AHR, as seen by decreased airway
resistance and elastance (Figure 6).
Effect of H2O2 administration on mucus deposition and
lung remodeling. To evaluate mucus production, sections of
lung tissue were stained with periodic acid-Schiff. The
analysis of airway mucins demonstrated significant metapla-
sia of goblet cells and mucus accumulation at 48 h after the
last OVA challenge in actively sensitized mice (Figures 5e
and g) in comparison with the control group (PBS) (Figure 5f).
Treatment with H2O2 reduced OVA-induced mucus accumu-
lation and the percentage of mucus producing cells to
values similar to those observed in nonallergic controls
(Figures 5e, f and h). The lung sections stained with Gomori
trichrome demonstrated that OVA mice had increased
peribronchiolar matrix deposition as compared with the
PBS mice (Figures 5i–l). Quantitative analyses demonstrated
that delayed treatment with H2O2 prevented extracellular
matrix deposition in challenged mice (Figures 5i and l).
Furthermore, H2O2 treatment decreased concentrations
of CCL11, CCL24, IL-4, IL-5 and TNF-α that were measured
at 48 h after antigen challenge (Table 1).
Discussion
There is strong evidence indicating an important role for
eosinophils in the pathogenesis of allergic diseases through
the release of a variety of inflammatory mediators, including
MBP, EPO and cytokines.1 Here, we evaluated the role of
endogenous and effects of exogenous administration of H2O2
in the context of resolution of allergic inflammation. The results
presented here can be summarized as follows: (i) treatment
with H2O2 or strategies that enhanced H2O2 reduced
eosinophil accumulation in the BAL and lung tissue; (ii) H2O2
promoted resolution of inflammation by inducing caspase-
dependent apoptosis of eosinophils in vivo; (iii) H2O2 also
induced caspase-dependent apoptosis of a human eosino-
philic cell line in vitro. (iv) H2O2 derived from NADPH oxidase
was necessary for natural resolution of allergic inflammation;
(v) finally, treatment with H2O2 decreased secretion of mucus,
Figure 2 ROS derived from NADPH oxidase is necessary for inflammation resolution. ROS production in WTor gp91phox− /− mice (a). Eosinophils 72 and 96 h after OVA in
gp91phox− /−mice and after apocynin treatment (b). Eosinophil peroxidase (c). Lung sections of PBS (d), WT (e) gp91phox− /− (f). H&E. 100 × . Scale 50 μm. Data represent
mean± S.E.M. (n= 5). *Po0.05 versus control group
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extracellular matrix deposition, inflammatory cytokine produc-
tion and decreased AHR induced by antigen. Altogether, these
results demonstrate a clear proresolving effect of H2O2 in
allergic inflammation in vivo.
In our experiments, we have demonstrated that endogen-
ous or exogenous H2O2 resolved eosinophilic inflammation in
two different models of the allergic response. In the asthma
model, this event correlated with increased number of
Figure 3 H2O2 induces apoptosis of eosinophils. SOD (0.3 mg/kg), SOD+catalase (1.2 mg/kg), H2O2 (0.5 M) or vehicle (30 μl PBS) i.n. Apoptotic morphology (a) Cells
expressing Annexin V-FITC+CCR3+ (b). Eosinophils after zVAD-fmk administration (1 mg/kg, i.p) (c). Cell types. Red arrow normal eosinophil. Black arrow: eosinophil with
apoptotic morphology. PBS (d) asthma (e) SOD (f) H2O2 (g). 100 × Scale: 50μm. Data represent mean±S.E.M. (n= 5). *Po0.05 versus control mice. #Po0.05 versusOVAmice
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apoptotic eosinophils. This is similar to the role of H2O2 in a
model of arthritis, in which H2O2 limits inflammation asso-
ciated with induction of caspase-dependent apoptosis of
neutrophils.18 In fact, blockade of caspases with a pan-
caspase inhibitor, zVAD-fmk, prevented apoptosis and the
resolution of eosinophilic inflammation induced by H2O2
consistent with our previous studies on neutrophils. H2O2
has been shown to induce apoptosis in culture of different cell
types including human hepatocyte cells,29 epithelial cells,30
endothelial cells31 andmyocytes.32 Here, we demonstrate that
H2O2 also induced apoptosis of a human eosinophilic cell line,
as by assessed by flow cytometry, light microscopy and
cleavage of caspase-3 assessed by western blotting. The
experiments using Eol-1 cells suggest that this pathway may
be relevant in humans and clearly deserve further investiga-
tion in human disease. Indeed, ROS have been reported to
increase apoptosis of human eosinophils.33,34 Therefore, our
evidence suggests that resolution of eosinophilic inflammation
by endogenous or exogenous H2O2 is due to the capacity of
this molecule to induce caspase-dependent apoptosis of
eosinophils.
Results in gp91phox-deficient mice showed that influx was
not altered but persistency of eosinophils in tissues was
greatly prolonged. Moreover, the intranasal treatment with an
inhibitor of NADPH oxidase delayed the resolution of
inflammatory response. It has been reported that in conditions
of oxidative stress, the NADPH oxidase complex catalyzes
electron transfer from NADPH to molecular oxygen and
generates superoxide anions (O2
−). The superoxide dismu-
tase (SOD) degrades O2
− in H2O and produces H2O2.
23 Our
work is the first to describe the importance of the oxidative
pathway involving NADPH oxidase to resolve eosinophilic
response. This is consistent with other studies in mice, which
showed that gp91phox− /− mice had delayed resolution of
neutrophilic inflammation and this process was reversed by
administration of exogenous H2O2 in a model of antigen-
induced arthritis.18 These data support the concept that ROS,
which are generated by the phagocytic NADPH oxidase and
commonly considered harmful mediators of acute inflamma-
tion, have a role in limiting inflammation and may be pivotal in
resolving acute inflammation.35 Indeed, our results show that
H2O2 not only induces resolution of inflammation, but it is also
relevant in the context of the natural resolution of eosinophilic
inflammation. Recent data show that administration of SOD
accelerates resolution of inflammation associated to antigen-
induced arthritis resulting in increased number of apoptotic
neutrophils. This coincided with activation of caspase-3 and
increased Bax expression in neutrophils recovered from the
articular cavity.18 We also investigated whether reactive
nitrogen species (RNS) participate in the resolution of the
inflammatory response in the model of allergic asthma. It was
observed that in the absence of NO production by iNOS there
was no change in the resolution of allergic inflammation
(Supplementary Figure 5). RNS such as NO are involved in
the inflammatory process in the airways of asthmatic patients.
NO has also been shown to be involved in the regulation of
apoptosis: it can prevent or induce apoptosis depending upon
the cell type and the concentration in which it is produced.36–40
The data suggest that RNS are not essential for resolution of
allergic inflammation.
Our results showed that in addition to resolving eosinophilic
inflammation, treatment with H2O2 had major physiological
consequences in a model of allergic asthma. Indeed,
treatment with H2O2 greatly reduced eosinophil accumulation,
changes in airway reactivity, remodeling and mucus deposi-
tion induced by antigen challenge of immunized mice.
Cytokines, including IL-4, IL-5 and TNF-α, and chemokines
(CCL11 and CCL24) are thought to be involved in eosinophil
accumulation and linked to pathophysiology of allergic
disease.41–44 There is also evidence that IL-5 and TNF-α
promote eosinophil survival in vitro.45–47 In addition, CCL11
and CCL24 are important for eosinophil recruitment from the
blood to the parenchyma and then into the airway.48 However,
the evidence that antibody or drugs targeting these cytokines
or chemokine induce resolution of eosinophilic inflammation
in vivo is scanty. In addition, IL-4, IL-5 and TNF-α are essential
for the development of AHR, mucus production and fibrosis in
asthma.49–51 Similarly, chemokines, such as CCL11 and
CCL24, may also contribute to AHR and fibrogenesis in
Figure 4 H2O2 induces concentration and caspase-dependent apoptosis
in Eol-1 cells. Eol-1 cells with H2O2 (0.3 mM–3.0 mM) (a) or H2O2 (1 mM) and
Q-VD-OPh (10 μM) (b). Western blotting for cleaved caspase-3 (17/19 kDa) and
GAPDH (37 kDa) (c). Data represent mean± S.E.M. n= 3. *Po0.05, **Po0.01,
***Po0.001. Western blots representative on three experiments
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animal models of asthma.42,48 In our studies, there was a
marked decrease in levels of these cytokines, which accom-
panied the resolution of the eosinophil numbers. Resolution of
inflammation is known to exert potent anti-inflammatory
effects and decrease of production of proinflammatory
cytokines,52,53 suggesting that decreased levels of TNF, IL-5,
IL-4 and chemokines are likely a consequence of the anti-
inflammatory action of the resolution process. Alternatively, it
is also possible that ROS induced a primary decrease of
cytokines that could have then accounted for eosinophil
apoptosis and in the resolution of eosinophilic inflammation.
The latter possibility is more difficult to ascertain in the in vivo
situation and clearly more studies are needed to convincingly
show that blockade of cytokines alter survival of eosinophils
in vivo, as demonstrated in vitro. Whatever the mechanism,
direct effect on eosinophils (shown here) or an indirect action
via decrease on survival factors, our data clearly demonstrate
the proresolving effects of H2O2 in the context of eosinophilic
inflammation.Taken together our findings show that exogen-
ous or endogenous generation of H2O2 resolve allergic
inflammation by inducing eosinophil apoptosis in a caspase-
dependent manner. Induction of eosinophil apoptosis by H2O2
Figure 5 Effect of H2O2 on lung remodeling and mucus deposition. Leukocyte infiltrate around the bronchial region of the lung sections stained with hematoxylin and eosin
(H&E) or Sirius Red (pH 10.2) (a–d). Mucus production from airway stained with hematoxylin and Periodic acid-Schiff (PAS) (e–h). 400 × . Peribronchial fibrosis stained with
hematoxylin and eosin and a combination of Gomori trichrome (i–l). 200 ×. *Po00.5 versus control mice. #Po0.05 versus OVA mice
H2O2 resolves allergic inﬂammation
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decreases airway remodeling and dysfunction. These results
have fundamental implications to the basic concept of
inflammation resolution and may have therapeutic implica-
tions. Indeed, our results demonstrate that resolution of
eosinophilic inflammation by H2O2 maintains tissue integrity
and function. Restoration of tissue inflammation to home-
ostasis may reverse airway function and remodeling in
patients, a tenet that may be exploited for the development
of novel therapies for the treatment of asthma.
Materials and Methods
Ethics statement. Male C57/BL6 and gp91phox− /− mice (Gene Cybb; ES Cell
Line name CCE/EK.CE)54 (8–10 weeks) were bred and housed in a temperature-
controlled room with free access to water and food. Animal Care and Use
Committee and the study received prior approval from the local animal ethics
committee (Animal Ethics Review Board – Comitê de Ética em Experimentação
Animal-CETEA/Universidade Federal de Minas Gerais-UFMG (protocol number:
218/11).
Reagents and drugs. Superoxide dismutase (SOD) from bovine erythrocytes,
catalase, H2O2, ovalbumin, Z-VAD-fmk, propidium iodide (PI) and 4,5-diamino-
fluoresceína-diacetato (DAF-2DA) were purchase from Sigma (St. Louis, MO, USA).
Apo DETECT ANNEXIN-V-FITC KIT 2,7-diclorodihidrofluoresceína-diacetato
(DCF-DA) and dihidrorodamine-123 (DHR-123) were purchase from Invitrogen
(Life Technologies, São Paulo, Brazil). Antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Q-VD-OPh (R&D Systems, Minneapolis,
MN, USA), annexin-V-FLUOS (Roche, Mannheim, Germany).
Eol-1 cell culture and apoptosis induction. Human eosinophilic cell
line (Eol-1 cells) was maintained in RPMI-1640 medium (PAA) with 2% FBS
(Biosera), penicillin (100 U/ml) and streptomycin (100 U/ml) (PAA). Cells were
aliquoted (2 × 106 cells/ml) and incubated with H2O2 (Thermo Fisher Scientific,
Waltham, MA, USA), Q-VD-OPh (R&D Systems) or combinations of these either in
96-well-flat bottomed-plates (final volume of 150 μl) or in 2 ml Eppendorf tubes (final
volume of 500 μl) in a humidified, 37 °C incubator at 5% CO2 atmosphere or on a
shaking, temperature-controlled heat block. Q-VD-OPh stock was initially dissolved
in dimethyl sulphoxide (Sigma) then diluted in buffer yielding a final concentration of
0.2%; a corresponding DMSO control of 0.2% was assessed as an appropriate
vehicle control. Apoptosis was assessed by flow cytometry with a BD-LSR Fortessa
(Becton Dickinson Biosciences, San Jose, CA, USA) using annexin-V-FLUOS
(Roche) in combination with propidium iodide (PI) (Sigma) as described.55 Data
were analyzed using Flowjo software (TreeStar, Ashland, OR, USA). Morphological
apoptotic changes were assessed by light microscopy of DiffQuick stained
cytocentrifuged cells.55
Western blotting. Cells at a concentration of 2 × 106 cells/ml per condition
were incubated with H2O2 (Thermo Fisher Scientific), Q-VD-OPh (R&D Systems) or
combinations of these at 37 °C on a shaking heat block for 4 h. Eol-1 cells were
pelleted by centrifugation at 3000 × g for 60 s and resuspended with whole-cell lysis
buffer. Sample was incubated on ice for 10 min then NP-40 was added, briefly
vortexed and centrifuged for 20 min at 3000 × g. Supernatant was removed and the
remaining cell pellet was resuspended in sample buffer before boiling at 95 °C for
5 min. Lysate were run on 12% precast gels (Thermo Fisher Scientific, Rockford, IL,
USA) and transferred onto PVDF (Immobilon-P, Millipore, Herts, UK). Membranes
were blocked for 1 h in 5% (wt/vol) dried milk/TBS/0.1% Tween-20 before probing
with antibodies to cleaved caspase-3 diluted 1 : 500 (Cell Signaling Technologies) at
40C overnight or GAPDH diluted 1 : 20 000 (Sigma-Aldrich, St. Louis, MO, USA) 1 h
at room temperature. Following 3 × 5 min washes in TBS/0.1%Tween-20, the blots
were incubated with HRP-conjugated secondary antibody (Dako, Glostrup,
Denmark) diluted 1 : 2500 for 1 h at room temperature before incubation with
ECL (GE Healthcare, Bucks, UK) exposure to BioMax MS-1 X-ray-sensitive film,
and processing (X-Ograph Imaging Systems, Wilts, UK).
Induction of asthma. All mice were sensitized intraperitoneally (i.p.) with
100 μg of OVA (albumin from chicken egg white - A5503, Sigma-Aldrich) in 2%
alum (aluminum hydroxide gel adjuvant; Brenntag) on day 0, then challenged
intranasally (i.n.) on days 8–10 with 10 μg of OVA or PBS.56 The treatments with
apocynin, SOD, H2O2 and catalase were performed i.n. and the zVAD-fmk (Tocris
Bioscience) was administered i.p.
Induction of pleurisy. Mice were immunized with OVA adsorbed to aluminum
hydroxide gel as described.52 Briefly, mice were injected subcutaneously (s.c.) on
days 1 and 7 with 0.2 ml of a solution containing 100 mg of OVA and 70 mg of
aluminum hydroxide. Sensitized mice were then challenged with OVA (1 mg/cavity,
in a total volume of 100 ml intrapleurally, i.pl) or PBS. Cells present in the pleural
cavity were collected at different times by washing the cavity with 2 ml PBS and total
cell counts performed in a modified Neubauer chamber using Turk’s stain.
Differential cell counts were performed on cytocentrifuge preparations (Shandon
Cytospin III), stained with May–Grünwald–Giemsa using standard morphological
criteria to identify cell types. The results are presented as the number of cells/cavity.
BAL analysis. BAL was performed to obtain leukocytes present in the alveolar
space. Mice were killed by anesthetic overdose and the trachea of each animal was
exposed and cannulated with a polypropylene catheter of 1.7 mm. Airways were
washed with 2 ml of ice-cold PBS. Total cell counts were performed in a modified
Neubauer chamber using Turk’s stain. Differential cell counts were performed on
cytocentrifuge preparations (Shandon Cytospin III), stained with May–Grünwald–
Giemsa using standard morphological criteria to identify cell types. The results are
Figure 6 Airway resistance and dynamic elastance after increasing methacho-
line doses. H2O2 (0.5 M) or vehicle (30 μl PBS) was administered i.n. instillation 24 h
after asthma induction. Airway resistance (a) and elastance (b) was measured in
response to increasing doses of methacholine (3, 9, 27, 81). Data represent
mean ±S.E.M. (n= 10). *Po0.05 versus vehicle group. #Po0.05 versus OVA mice
Table 1 Levels of cytokines in lung (pg/ml)
Cytokines PBS OVA H2O2
CCL11 743± 152 9109± 5063a 5845± 2048b
CCL24 903± 245 11956± 6304a 6896± 1143b
IL-4 110± 32 238± 149a 127± 34b
IL-5 847± 84 1226± 445a 829± 140b
TNF-α 182± 41 310± 135a 157± 45b
Abbreviations: TNF-α, tumor necrosis factor alpha; IL-4, interleukin-4; IL-5,
interleukin-5
aSignificantly different from the control group (Po0.05)
bSignificantly different from the vehicle group (Po0.05)
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presented as the number of cells/BAL. In a separated set of experiments, apoptotic
cells were morphologically identified in cytocentrifuged slides, which were also
positively stained for cleaved caspase-3 (Alexa Fluor 488 rabbit anti-mouse cleaved
caspase-3; Cell Signaling; 1 : 50). Fluorescence intensity was measured offline
using Volocity software 6.3 (Perkin–Elmer, Waltham, MA, USA) and fluoresce profile
was assessed using Image J (NIH).57
Histological analysis. The lung was prepared as described.58 Briefly, lungs
were removed 24 h after the last challenge and fixed in Milloning buffer solution
(pH 7.4) with 4% paraformaldehyde. For analysis of leukocyte infiltrate around the
bronchial region, the lung sections were stained with hematoxylin and eosin (H&E)
or were subjected to Sirius Red (pH 10.2) staining (Llewellyn's Sirus Red Direct Red
80, CI 35780; Aldrich, Milwaukee, WI, USA). Results were expressed as leukocytes/
104 μm2. Mucus production was analyzed from tissue sections stained with Harris
hematoxylin stain and a combination of Periodic acid-Schiff (PAS) stain (Schiff's
reagent, Merck, Rio de Janeiro, Brazil). Photomicrographs of airways obtained at
400 × magnification were analyzed using the software Image-Pro Plus (Image-Pro
Plus, 4.1; Media Cybernetics, Houston, TX, USA). Nine to twelve bronchial areas
per lung were outlined and quantified. Results were expressed as PAS positive area
(pixels/μm2). Peribronchial fibrosis was analyzed from tissue sections stained with
hematoxylin and eosin stain and a combination of Gömöritrichrome stain (Trichrome
Stain LG Solution; Sigma-Aldrich). Photomicrographs of airways obtained at 200 ×
magnification were analyzed using the software Image-Pro Plus. Eight to twelve
peribronchial area per lung were outlined and quantified.59 Results were expressed
as extracellular matrix deposition area (μm2).
Assessment of leukocyte apoptosis. Apoptosis was assessed as
described.52,60 Briefly, cells (5 × 104) collected 48 h after antigen challenge were
cytocentrifuged, fixed and stained with May–Grunwald–Giemsa and counted using
oil immersion microscopy (×100 objective) to determine the proportion of cells with
distinctive apoptotic morphology (cell shrinkage, chromatin condensation, nuclear
fragmentation and maintenance of membrane integrity). Twenty-five fields were
counted per slide and the results expressed as the mean± S.E.M. of number
of apoptotic cells in 25 fields. Assessment of apoptosis was also performed by
flow cytometry using commercial kit annexin-V-FITC (Invitrogen) following the
instructions of the manufacturer in cells previously stained with the following Abs to
extracellular markers for 30 min on ice: anti-mouse CCR3 mAb (BD Biosciences,
San Jose, CA, USA) or anti-mouse mAb CD3 (BD Biosciences). Flow cytometry
was performed using a FACS Canto flow cytometer (BD). At least 104 events were
recorded and analyzed using FlowJo software (FlowJo, LLC, Ashland, OR, USA).
Results are expressed as cells undergoing early stage apoptosis quantified by
staining with annexin-V but not PI.
ELISA analysis. Murine IL-4, IL-5, TNF-α, CCL11 and CCL24 levels were
measured in right lung tissue samples by means of ELISA technique using
commercial DuoSet kits R&D Systems following the instructions of the
manufacturer. Results were expressed in levels of cytokines per lung (pg/ml).
Quantification of eosinophil accumulation in lung. Pulmonary EPO
activity was determined to estimate eosinophil recruitment into the lung parenchyma
as described.61 Absorbance was read in an ELISA reader (Expert Plus ASYS
Hitech GmbH, Eugenorf, Austria) at 492 nm. Values are expressed in O.D.
Determination of the production of reactive oxygen species and
nitrogen by fluorimetry. Leukocytes obtained from the BAL were incubated
separately with the probes '-7' dicloro-dihidrofluoesceínadiacetate (DCF-DA 20 uM),
dihidrorodaminadiacetate 123 (DHR-123 5 uM) of 4,5-diaminofluorescein (DAF-2DA
10 uM) for 30 min in an oven at 37 °C. This stage of the experiment was performed in
the dark, because the markers are photosensitive. The reading of fluorescence was
performed in a fluorescence spectrophotometer (Synergy 2, Biotek, Winooski, VT,
USA) with wavelengths of excitation and emission of 488 and 515 nm, respectively.
Invasive assessment of respiratory mechanics. Airway reactivity was
assessed as a change in airway function after challenge with aerosolized methacholine
in a FinePoint R/C Buxco Platform. The parameters were measured as previously
described.62 The analyses were performed 48 h after the last OVA challenge.
Statistical analysis. ANOVA followed by Student Newman–Keuls was applied
to comparison of multiple groups. In order to test statistical significance between two
groups we used the unpaired Student’s t-test (GraphPad Software, San Diego, CA,
USA). All in vitro experiments were performed at least three times with each
experiment carried out in triplicate. All in vivo experiments included six mice per
group. Data were expressed as the mean ± S.E.M. Differences were considered
significant at Po0.05.
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